Aptimmune Biologics was featured as a successful university-related startup at The Association of American Universities and the Association of Public and Land-grant Universities University Innovation and Entrepreneurship Showcase in December.
Aptimmune specializes in developing autogenous mucosal vaccines for viral diseases that are costly to the swine industry. Founded by Dr. Federico Zuckermann, a University of Illinois Urbana-Champaign veterinary medicine faculty member, the company graduated from EnterpriseWorks in 2018.
The third annual University Innovation and Entrepreneurship Showcase was held virtually on Dec. 7-11. The showcase spotlighted 22 startup companies from across the nation that have created products and services using federally funded, university-based research.
Aptimmune is now based in St. Louis.